Clinical Features, Genome Epidemiology, and Antimicrobial Resistance Profiles of <i>Aeromonas</i> spp. Causing Human Infections: A Multicenter Prospective Cohort Study
Aki Sakurai(Fujita Health University), Yohei Doi(Fujita Health University)
Cited by 25
Related Papers
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Clinical outcomes and bacterial characteristics of carbapenem-resistant Klebsiella pneumoniae complex among patients from different global regions (CRACKLE-2): a prospective, multicentre, cohort study
|The Lancet Infectious Diseases|2021|338
Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study
|The Lancet Infectious Diseases|2020|328
Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by<i>Enterobacter</i>,<i>Citrobacter</i>or<i>Serratia</i>species: a systematic review with meta-analysis
|Journal of Antimicrobial Chemotherapy|2015|86
Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition
|Clinical Microbiology and Infection|2016|83